Recent advances of metal binding protein lactoferrin as an anti-microbial agent

Current Bioactive Compounds

Volumn 5, Issue 3, 2009, Pages 226-233

  Gupta, Isha ^a   Sehgal, Rakesh ^a   Kanwar, Rupinder K ^b   Sehgal, Alka ^c   Kanwar, Jagat R ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b DEAKIN UNIVERSITY   (Australia)

^c GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IRON CHELATING AGENT; LACTOFERRIN; MILK PROTEIN;

ANTIMICROBIAL ACTIVITY; ANTIPARASITIC ACTIVITY; ANTIVIRAL ACTIVITY; BABESIA CABALLI; BACTERIOSTASIS; EIMERIA STIEDAI; ENTAMOEBA HISTOLYTICA; ENZYME ACTIVITY; GIARDIA LAMBLIA; GROWTH INHIBITION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IRON TRANSPORT; LETHALITY; MENSTRUATION; NONHUMAN; PARASITE; PH; PLASMODIUM FALCIPARUM; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; REVIEW; TEMPERATURE; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRICHOMONAS VAGINALIS; TRYPANOSOMA CRUZI; UTERINE CERVICITIS; VAGINA DISCHARGE;

EID: 70449840145     PISSN: 15734072     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340709789054795     Document Type: Review

References (90)

1. Kanwar, J.R., Palmano, K.P., Sun, X., Kanwar, R.K., Gupta, R., Haggarty, N., Rowan, A., Ram, S., Krissansen, G.W. (2008) Iron-saturated' lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy. Immunol. Cell Biol., 86, 277-288.
2. Kanwar, J.R., Kanwar, R., Puri, M. (2008) Milk proteins and human health. In: Joshi, V.K., Singh, R.S., Eds., Food Biotechnology: Principles and Practices. Ane Publisher: India. pp. 1-66.
3. Kanwar, J.R., Kanwar, R.K., Sun, X., Punj, V., Matta, H., Morley, S.M., Parratt, A.C., Puri, M., Sehgal, R. (2009) Molecular and biotechnological advances in milk proteins in relation to human health. Curr. Protein Peptide Sci., 10(4), 308-338.
4. Arnold, R.R., Russel, J.E., Champion, W.J., Brewer, M., Gauthier, J.J. (1982) Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation. Infect. Immun., 35, 792-799. (Pubitemid 12185031)
5. Valenti, P., Berlutti, F., Conte, M.P., Longhi, C., Seganti, L. (2004) Lactoferrin functions: current status and perspectives. J. Clin. Gastroenterol., 38, S127-S129.
6. Jenssen, H., Hancock, R.E. (2009) Antimicrobial properties of lactoferrin. Biochimie, 91, 19-29.
7. Shi, Y., Kong, W., Nakayama, K. (2000) Human lactoferrin binds and removes the hemoglobin receptor protein of the periodotontopathogen Porphyromonas gingivalis. J. Biol. Chem., 275, 30002-30008. (Pubitemid 30751304)
8. Farnaud, S., Evans, R.W. (2003) Lactoferrin: a multifunctional protein with antimicrobial properties. Mol. Immunol., 40, 395-405. (Pubitemid 37244032)
9. Viejo-Diaz, M., Andres, M.T., Fierro, J.F. (2004) Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity. Antimicrob. Agents. Chemother., 48, 1242-1248.
10. Singh, P.K., Parsek, M.R., Greenberg, E.P., Wilsh, M.J. (2002) A component of innate immunity prevents bacterial biofilms development. Nature, 417, 552-555.
11. Yamauchi, K., Tomita, M., Giehl, T.J., Ellison, R.T. (1993) Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun., 61, 719-728. (Pubitemid 23030865)
12. Tomita, M., Takase, M., Bellamy, W., Shimamura, S. (1994) A review: the active peptide of lactoferrin. Acta Paediatr. Jpn., 36, 585-591.
13. Lonnerdal, B., Iyer, S. (1995) Lactoferrin: molecular structure and biological function. Annu. Rev. Nutr., 15, 93-110.
14. Orsi, N. (2004) The antimicrobial activity of lactoferrin: Current status and perspectives. BioMetals, 17, 189-196. (Pubitemid 38987136)
15. Kuipers, M.E., de Vries, H.G., Eikelboom, M.C., Meijer, D.K., Swart, P.J. (1999) Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob. Agents Chemother., 43, 2635-2641.
16. Diarra, M.S., Petitclerc, D., Lacasse, P. (2002) Effect of lactoferrin in combination with penicillin on the morphology and the physiology of Staphylococcus aureus isolated from bovine mastitis. J. Dairy Sci., 85, 1141-1149. (Pubitemid 38583363)
17. van der Strate, B.W., De Boer, F.M., Bakker, H.I., Meijer, D.K., Molema, G., Harmsen, M.C. (2003) Synergy of bovine lactoferrin with the anti-cytomegalous drug cidofor in vitro. Antiviral. Res., 58, 159-165. (Pubitemid 36559610)
18. Upcroft, J.A., Campbell, R.W., Benkali, K., Upcroft P., Vanelle, P. (1999) Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp. Antimicrob. Agents Chemother., 43, 73-76. (Pubitemid 29069202)
19. Wassmann, C., Hellberg, A., Tannich, E., Bruchhaus, I. (1999) Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase. J. Biol. Chem., 274, 26051-26056. (Pubitemid 129520027)
20. Tanaka, T., Omata, Y., Narisawa, M. (1997) Growth inhibitory effect of bovine lactoferrin on Toxoplasma gondii tachyzoites in murine macrophages: role of radical oxygen and inorganic nitrogen oxide in Toxoplasma growth-inhibitory activity. Vet. Parasitol., 68, 27-33. (Pubitemid 27128058)
21. Turchany, J.M., McCaffery, J.M., Aley, S.B., Gillin, F.D. (1997) Ultrastructural effects of lactoferrin binding on Giardia lamblia trophozoites. J. Eukaryot. Microbiol., 44, 68-72.
22. Weinberg, G.A. (1994) Iron chelators as therapeutic agents against Pneumocystis carinii. Antimicrob. Agents Chemother., 38 (5), 997-1003.
23. Beaumont, S.L., Maggs, D.J., Clarke, H.E. (2003) Effects of bovine lactoferrin on in vitro replication of feline herpesvirus. Vet. Ophthalmol., 6, 245-250.
24. Fritsch, G., Sawatzki, G., Treumer, J., Jung, A., Spira, D.T. (1987) Plasmodium falciparum: inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocin. Exp. Parasitol., 63, 1-9. (Pubitemid 17006803)
25. Ikadai, H., Tanaka, T., Shibahara, N., Tanaka, H., Matsuu, A., Kudo, N., Shimazaki, K., Igarashi, I., Oyamada, T. (2005) Short report: Inhibitory effect of lactoferrin on in vitro growth of Babesia caballi. Am. J. Trop. Med. Hyg., 73, 710-712. (Pubitemid 41446718)
26. Britigan, B.E., Lewis, T.S., McCormick, M.L., Wilson, M.W. (1998) Evidence for the existence of a surface receptor for ferrictransferrin associated with the plasma membrane of the protozoan parasite Leishmania donovani. Adv. Exp. Med. Biol., 443, 135-140.
27. Weinberg, E.D. (1999) The role of iron in protozoan and fungal infectious diseases. J. Eukaryot. Microbiol., 46, 231-238. (Pubitemid 29284923)
28. Leon-Sicairos, N., Reyez-Lopez, M., Canizalez-Roman, A., Bermudez-Cruz, R., Serrano-Luna, J., Arroyo, R., de la Garza, M. (2005) Human lactoferrin: endocytosis and use as iron source by the parasite Entamoeba histolytica. Microbiology, 151, 3859-3871. (Pubitemid 41829967)
29. DiBiase, A.M., Pietrantoni, A., Tinari, A., Siciliano, R., Valenti, P., Antonini, G., Seganti, L., Superti, F. (2003) J. Med. Virol., 69, 495-502.
30. Andersen, J.H., Osbakk, S.A., Vorland, L.H., Traavik, T., Gutteberg, T.J. (2003) Antiviral. Res., 51, 141-149.
31. Das, N.K., Biswas, S., Solanki, S., Mukhopadhyay, C.M. (2009) Leishmania donovani depletes labile iron pool to exploit iron uptake capacity of macrophage for its intracellular growth. Cell Microbiol., 11, 83-94.
32. Gonzalez-Chavez, S.A., Arevalo-Gallegos, S., Rascon-Cruz, Q. (2009) Lactoferrin, structure, function and applications. Int. J. Antimicrob. Agents, 33, 301.e1-301.e8.
33. Cintra, W.M., Silva-Filho, F.C., De Souza, W. (1986) The surface charge of Toxoplasma gondii: a cytochemical and electrophoretic study. J. Submicrosc. Cytol., 18, 773-781.
34. Isamida, T., Tanaka, T., Omata, Y., Yamauchi, K., Shimazachi, K., Saiko, A. (1998) Protective effect of lactoferrin against Toxoplasma gondii infection in mice. J. Vet. Med. Sci., 60, 241-244. (Pubitemid 128527552)
35. Omata, Y., Satake, M., Maeda, R., Saito, A., Shimazaki, K., Yamauchi, K., Uzuka, Y., Tanabe, S., Sarashina, T., Mikami, T. (2001) Reduction of the infectivity of Toxoplasma gondii and Eimeria stiedai sporozoites by treatment with bovine lactoferricin. J. Vet. Med. Sci., 63, 187-190. (Pubitemid 33674513)
36. Puddu, P., Borghi, P., Gessani, S., Valenti, P., Belardelli, F., Seganti, L. (1998) Int. J. Biochem. Cell Biol., 30, 1055-1062.
37. Groot, F., Geijtenbeek, T.B., Sanders, R.W., Baldwin, C.E., Sanchez-Hernandez, M., Floris, R., van Kooyk, Y., de Jong, E.C., Berkhout, B. (2005) J. Clin. Invest., 115, 3256-3264.
38. Berkhout, B., van Wamel, J.L., Beljaars, L., Meijer, D.K., Visser, S., Floris, R. (2002) Antiviral Res., 55, 341-355.
39. Tanaka, T., Abe, Y., Kim, W.S., Xuan, X., Nagasawa, H., Igarash, I., Kumura, H., Shimazaki, K. (2003) The detection of bovine lactoferrin binding protein on Toxoplasma gondii. J. Vet. Med. Sci., 65, 1377-1380. (Pubitemid 41365443)
40. Dzitko, K., Dziadek, B., Dziadek, J., Długońska, H. (2007) Toxoplasma gondii: inhibition of the intracellular growth by human lactoferrin. Pol. J. Microbiol., 56, 25-32. (Pubitemid 46814167)
41. Arnold, R.R., Brewer, M., Gauthier, J.J. (1980) Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect. Immun., 28, 893-898. (Pubitemid 10122520)
42. Griffiths, E.A., Duffy, L.C., Schanbacher, F.L., Dryga, D., Leavens, A., Neishwander, R.L., Qiao, A., DiRienzo, D., Ogra, P. (2003) In vitro growth responses of bifidobacteria and enteropathogens to bovine and human lactoferrin. Dig. Dis. Sci., 48, 1324-1332. (Pubitemid 36793911)
43. Botteon, P., Massard, C., Botteon, R., Loss, Z., Linhares, G. (2002) Seroprevalence of Babesia equi in three breeding systems of equines. Parasitol. Latinoam (Bras)., 57, 141-145.
44. Tachezy, J., Kulda, J., Bahnikova, I., Suchan. P., Razga, J., Schrevel, J. (1996) Tritrichomonas foetus: iron acquisition from lactoferrin and transferring. Exp. Parasitol., 83, 216-228. (Pubitemid 26274070)
45. Lehker, M.W., Alderete, J.F. (1992) Iron regulates growth of Trichomonas vaginalis and the expression of immunogenic trichomonad protein. Mol. Microbiol., 6, 123-132.
46. Jenssen, H., Anderson, J.H., Uhlin-Hansen, L., Gutterberg, T.J., Rekdal, O. (2004) Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate. Antiviral Res., 61, 101-109. (Pubitemid 37506097)
47. Sinnis, P., Willnow, T.E., Briones M.R., Herz, J., Nussenzweig, V. (1996) Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes. J. Exp. Med., 184, 945-954. (Pubitemid 26313552)
48. Shakibaei, M., Frevert, U. (1996) Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans. J. Exp. Med., 184, 1699-1711. (Pubitemid 26404462)
49. Drobni, P., Näslund, J., Evander, M. (2004) Lactoferrin inhibits human papillomavirus binding and uptake in vitro. Antiviral Res., 64, 63-68. (Pubitemid 39286749)
50. Marchetti, M., Trybala, E., Superti, F., Johansson, M., Bergstrom, T. (2004) Virology, 318, 405-413.
51. Turchany, J.M., Aley, S.B., Gillin, F.D. (1995) Giardicidal activity of lactoferrin and N-terminal peptides. Infect. Immun., 63, 4550-4552.
52. Tachezy, J., Suchan, P., Schrevel, J., Kulda, J. (1998) The host-protein independent iron uptake by Tritrichomonas foetus. Exp. Parasitol., 90, 155-163.
53. Pritt B.S., Clark C.G. (2008) Amebiasis. Mayo. Clin. Proc., 83, 1154-1160.
54. Leon-Sicairos, N., Lopez-Soto, F., Reyes-Lopez, M., Godinez-Vargas, D., Ordaz-Pichardo, C., de la Garza, M. (2006) Amoebicidal activity of milk, apo-lactoferrin, sIgA and lysozyme. Clin. Med. Res., 4, 106-113. (Pubitemid 44047363)
55. Leon-Sicairos, N., Reyes-Lopez, M., Ordaz-Pichardo, C., de la Garza, M. (2006) Microbicidal action of lactoferrin and lactoferricin and their synergistic effect with metronidazole in Entamoeba histolytica. Biochem. Cell Biol., 84, 327-336. (Pubitemid 44341307)
56. Bennett, R.M., Bagby, G.C., Davis, J. (1981) Calcium-dependent polymerization of lactoferrin. Biochem. Biophys. Res. Commun., 101, 88-95.
57. Brandenburg, K., Jurgens, G., Muller, M., Fukuoka, S., Koch, M.H. (2001) Biophysical Characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol. Chem., 382, 1215-1225. (Pubitemid 32894028)
58. Sommer, U., Costello, C.E., Hayes, G.R., Beach, D.H., Gilbert, R.O., Lucas, J.J., Singh, B.N. (2005) Identification of Trichomonas vaginalis cysteine proteases that induce apoptosis in human vaginal epithelial cells. J. Biol. Chem., 280, 23853-23860. (Pubitemid 40884872)
59. Kummer, S., Hayes, G.R., Gilbert, R.O., Beach, D.H., Lucas, J.J., Singh, B.N. (2008) Induction of human host cell apoptosis by Trichomonas vaginalis cysteine proteases is modulated by parasite exposure to iron. Microb. Pathog., 44, 197-203. (Pubitemid 351163527)
60. Alderete, J.F., Provenzano, D., Lehker, M.W. (1995) Iron mediates Trichomonas vaginalis resistance to complement lysis. Microb. Pathog., 19, 93-103.
61. Kucknoor, A.S., Mundodi, V., Alderete, J.F. (2005) Adherence to human vaginal epithelial cells signals for increased expression of Trichomonas vaginalis genes. Infect. Immun., 73, 6472-6478. (Pubitemid 41368809)
62. Ryu, J.S., Choi, H.K., Min, D.Y., Ha, S.E., Ahn, M.H. (2001) Effect of iron on the virulence of Trichomonas vaginalis. J. Parasitol., 87, 457-460.
63. Hernandez-Gutierrez, R., Ortega-Lopez, J., Arroyo, R. A. (2003) 39-kDa cysteine proteinase CP39 from Trichomonas vaginalis, which is negatively affected by iron may be involved in trichomonal cytotoxicity. J. Eukaryot. Microbiol., 50, 696-698. (Pubitemid 38043079)
64. Lehker, M.W., Alderete, J.F. (1990) Properties of Trichomonas vaginalis grown under chemostat controlled growth conditions. Genitourin. Med., 66, 193-199.
65. Leon-Sicairos, C.R., Leon-Felix, J., Arroyo, R. (2004) tvcp12: a novel Trichomonas vaginalis cathepsin L-like cysteine proteinase-encoding gene. Microbiology, 150, 1131-1138. (Pubitemid 38744712)
66. Tsai, C.D., Liu, H.W., Tai, J.H. (2002) Characterization of an iron-responsive promoter in the protozoan pathogen Trichomonas vaginalis. J. Biol. Chem., 277, 5153-5162.
67. Ong, H.M., Hsu, H.W., Liu, C.H., Chu, J.H., Tsai, C.D. (2006) Multifarious transcriptional regulation of adhesion protein gene ap65-1 by a novel Myb1 protein in the protozoan parasite Trichomonas vaginalis. Eukaryot. Cell, 5, 391-399.
68. Crouch, M.V., Alderete, J.F. (2001a) Trichomonas vaginalis has two fibronectin like iron-regulated genes. Arch. Med. Res., 32, 102-107.
69. Alderete, J.F., Nguyen, J., Mundodi, V., Lehker, M.W. (2004) Heme-iron increases levels of AP65-mediated adherence by Trichomonas vaginalis. Microb. Pathog., 36, 263-271. (Pubitemid 38388256)
70. Crouch, M.L., Benchimol, M., Alderete, J.F. (2001b) Binding of fibronectin by Trichomonas vaginalis is influenced by iron and calcium. Microb. Pathog., 31, 131-144. (Pubitemid 32783432)
71. Pramanik, J.M., Maili, B.N., Shah, R.S., Donde, U.M. (1999) Lactoferrin in cervical mucus as a biochemical marker for inflammation. Indian J. Clin. Bio., 14, 229-236.
72. Otsukia, K., Yoda, A., Saito, H., Mitsuhashi, Y., Toma, Y., Shimizu, Y., Yanaihara, T. (1999) Amniotic fluid lactoferrin in intrauterine infection. Placenta, 20, 175-179. (Pubitemid 29121812)
73. World Health Organization. (1995) An overview of selected curable sexually transmitted diseases. WHO Global Programme on AIDS Report.
74. Krieger, J.N., Wolner-Hanssen, P., Stevens, C., Holmes, K.K. (1990) Characteristics of Trichomonas vaginalis isolates from women with and without colpitis macularis. J. Infect. Dis., 161, 307-311. (Pubitemid 20056663)
75. Soper, D.E., Bump R.C., Hurt, W.G. (1990) Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am. J. Obstet. Gynecol., 163, 1016-1021.
76. Wölner-Hanssen, P., Krieger, J.N., Stevens, C.E., Kiviat, N.B., Koutsky, L., Critchlow, C., DeRouen, T., Hillier, S., Holmes, K.K. (1989) Clinical manifestations of vaginal trichomoniasis. JAMA, 261, 571-576.
77. Zhang, S.F., Begg, C.B. (1994) Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int. J. Epidemiol., 23, 682-690.
78. Laga, M., Manoka, A., Kiravu, M., Malele, B., Tuliza, M., Nzila, N., Goeman, J., Behets, F., Batter, V., Alary, M., Heyward, W.L., Ryder, R.W., Piot, P. (1993) Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS, 7, 95-102. (Pubitemid 23069039)
79. Wasserheit, J.N. (1992) Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm. Dis., 19, 61-77.
80. Lehker, M.W., Sweeney, D. (1999) Trichomonad invasion of the mucous layer requires adhesins, mucinases, and motility. Sex Transm. Infect., 75, 231-238.
81. Alderete, J.F., Deme, P., Gomboova, A., Valent, M., Fabuova, M., Janoská, A., Tefanovic, J., Arroyo, R. (1998) A specific parasitism of purified vaginal epithelial cells by Trichomonas vaginalis. Infect. Immun., 56, 2558-2562.
82. Arroyo, R., Engbring, J., Alderete, J.F. (1992) Molecular basis of host epithelial cell recognition by Trichomonas vaginalis. Mol. Microbiol., 6(7), 853-862.
83. Crouch M.L., Alderete, J.F. (1999) Trichomonas vaginalis interactions with fibronectin and laminin. Microbiology, 145, 2835-2843.
84. Costa e Silva Filho, F., de Souza W., Lopes, J.D. (1998) Presence of laminin-binding proteins in trichomonads and their role in adhesion. Proc. Natl. Acad. Sci. USA, 85, 8042-8046.
85. Gorrell, T.E. (1985) Effect of culture medium content on the biochemical composition and metabolism of Trichomonas vaginalis. J. Bacteriol., 161, 1228-1230.
86. Budilova, M., Kulda, J. (1997) Further studies on the effect of ferric ammonium citrate on the virulence of Tritrichomonas foetus to mice. J. Protozool., 24, 49.
87. Garcia A.F., Chang T.H., Benchimol, M., Klumpp, D.J., Lehker, M.W., Alderete J.F. (2003) Iron and contact with host cells induce expression of adhesins on surface of Trichomonas vaginalis. Mol. Microbiol., 47, 1207-1224.
88. Peterson, K.M., Alderete J.F. (1984) Iron uptake and increased intracellular enzyme activity follow host lactoferrin binding by Trichomonas vaginalis receptors. J. Exp. Med., 160, 398-410.
89. Lehker, M.W., Arroyo, R., Alderete J.F. (1991) The regulation by iron of the synthesis of adhesins and cytoadherence levels in the protozoan Trichomonas vaginalis. J. Exp. Med., 174, 311-318.
90. Yakuwa, K., Otsuki, K., Nakayama. K., Hasegawa, A., Sawada, M., Mitsukawa, K., Chiba, H., Nagatsuka, M., Okai, T. (2007) Recombinant human lactoferrin has a potential to suppresses uterine cervical ripening in preterm delivery in animal model. Arch. Gynecol. Obstet., 275, 331-334. (Pubitemid 46466370)